Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics
Neurocrine Biosciences, Inc. (NBIX)
Today's Latest Price: $94.31 USD
3.09 (3.39%)
Updated Apr 7 8:00pm
Add NBIX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NBIX Stock Summary
- NBIX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 429.96 -- higher than 93.17% of US-listed equities with positive expected earnings growth.
- NBIX's current price/earnings ratio is 214.56, which is higher than 98.29% of US stocks with positive earnings.
- The price/operating cash flow metric for Neurocrine Biosciences Inc is higher than 95.8% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to Neurocrine Biosciences Inc, a group of peers worth examining would be SSTI, NTCT, BLKB, MITK, and GDDY.
- NBIX's SEC filings can be seen here. And to visit Neurocrine Biosciences Inc's official web site, go to www.neurocrine.com.
NBIX Daily Price Range
NBIX 52-Week Price Range
NBIX Stock Price Chart More Charts
NBIX Price/Volume Stats
| Current price | $94.31 | 52-week high | $119.65 |
| Prev. close | $91.22 | 52-week low | $71.85 |
| Day low | $91.62 | Volume | 808,800 |
| Day high | $95.91 | Avg. volume | 846,276 |
| 50-day MA | $93.91 | Dividend yield | N/A |
| 200-day MA | $98.01 | Market Cap | 8.70B |
Neurocrine Biosciences, Inc. (NBIX) Company Bio
Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.
Top Stories View All
Best & Worst Performing Stock Industries for April 7, 2020
Best & Worst Performing Small Cap Stocks for April 7, 2020
Best & Worst Performing Mid Cap Stocks for April 7, 2020
Best & Worst Performing Large Cap Stocks for April 7, 2020
Best & Worst Performing Mega Cap Stocks for April 7, 2020
View All Top Stories
Loading social stream, please wait...